You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FF/UMEC/VI

Showing 1 - 25 of 509
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asthma Trial (FF/UMEC/VI, ELLIPTA, FF/VI)

Not yet recruiting
  • Asthma
  • FF/UMEC/VI
  • +2 more
  • (no location specified)
Feb 24, 2023

Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI, ELLIPTA)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • FF/UMEC/VI
  • ELLIPTA
  • (no location specified)
Aug 15, 2022

Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • FF/UMEC/VI
  • (no location specified)
Sep 7, 2022

Asthma Trial in China (FF/VI, FF/UMEC/VI, ELLIPTA)

Recruiting
  • Asthma
  • Xiamen, Fujian, China
  • +40 more
Oct 25, 2022

Asthma Trial (FF/UMEC/VI)

Not yet recruiting
  • Asthma
  • FF/UMEC/VI
  • (no location specified)
Nov 25, 2020

Pulmonary Disease, Chronic Obstructive Trial in Poland, Russian Federation, United States (FF/UMEC/VI, Tiotropium,

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • FF/UMEC/VI
  • +7 more
  • Andalusia, Alabama
  • +71 more
Jul 13, 2021

FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Telephone interviews
  • +4 more
  • London, United Kingdom
    GSK Investigational Site
Mar 5, 2020

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Gold River, California
  • +56 more
Oct 7, 2020

Pulmonary Disease, Chronic Obstructive Trial in Czechia, Germany, United States (budesonide/formoterol, albuterol/salbutamol,

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Mobile, Alabama
  • +56 more
Oct 7, 2020

Asthma Trial in Japan (FF/UMEC/VI 100/62.5/25 mcg, FF/UMEC/VI 200/62.5/25 mcg, Salbutamol)

Completed
Has Results
  • Asthma
  • FF/UMEC/VI 100/62.5/25 mcg
  • +3 more
  • Gifu, Japan
  • +12 more
May 14, 2020

Asthma Trial in Worldwide (FF/UMEC/VI (100/31.25/25) mcg, FF/UMEC/VI (100/62.5/25) mcg, FF/UMEC/VI (200/31.25/25) mcg)

Completed
Has Results
  • Asthma
  • FF/UMEC/VI (100/31.25/25) mcg
  • +10 more
  • Birmingham, Alabama
  • +408 more
Feb 26, 2021

Asthma Trial (FF/UMEC/VI, FP/SAL, Tiotropium)

Withdrawn
  • Asthma
  • FF/UMEC/VI
  • +8 more
  • (no location specified)
Mar 22, 2019

COPD Trial in Godollo (BDP/FF/GB, FlF/VI + Tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Godollo, Hungary
    Erzsebet Gondozohaz
Oct 28, 2021

Asthma in Children Trial in Haifa (Fluticasone furoate (FF)/Vilanterol (VI), Salbutamol)

Completed
  • Asthma in Children
  • Haifa, Israel
    Rambam Medical Center
Feb 10, 2021

Asthma Trial in Worldwide (FF/VI via ELLIPTA DPI, FF via ELLIPTA DPI)

Completed
Has Results
  • Asthma
  • FF/VI via ELLIPTA DPI
  • FF via ELLIPTA DPI
  • Hoover, Alabama
  • +183 more
Sep 12, 2022

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (FF/UMEC/VI, FF/VI, UMEC)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • FF/UMEC/VI
  • +4 more
  • La Plata, Buenos Aires, Argentina
  • +126 more
May 3, 2019

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (FF/UMEC/VI, Inhaled Corticosteroid, LAMA)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • FF/UMEC/VI
  • +4 more
  • Aschaffenburg, Bayern, Germany
  • +142 more
Aug 19, 2020

Using US Medical and Pharmacy Claim Records to Compare Resource

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Trelegy Ellipta
  • +3 more
  • Eden Prairie, Minnesota
    Optum
Mar 11, 2022

Chronic Obstructive Pulmonary Disease Dual Therapy Burden of

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • UMEC/VI
  • +5 more
  • Durham, North Carolina
    GSK Investigational Site
Jul 20, 2020

Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting

Withdrawn
  • Pulmonary Disease, Chronic Obstructive
  • Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
  • Fluticasone furoate/umeclidinium/vilanterol
  • Waterbury, Connecticut
  • +2 more
Apr 21, 2020

Asthma Trial (Beclomethasone Dipropionate/Formoterol Fumarate, Beclomethasone Dipropionate)

Not yet recruiting
  • Asthma
  • Beclomethasone Dipropionate/Formoterol Fumarate
  • Beclomethasone Dipropionate
  • (no location specified)
Mar 14, 2022

Systemic Corticosteroids in the Management of Asthma Attacks

Recruiting
  • Asthma
  • Visit 1: Clinical exam and questionnaires
  • +6 more
  • Sherbrooke, Quebec, Canada
    Centre de Recherche du CHUS
May 25, 2023

Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent

Recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +6 more
  • Ascorbic Acid
  • +12 more
  • Scottsdale, Arizona
  • +4 more
May 26, 2022

Asthma Trial in Edegem (Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI, Reference product 1 (R1): CHF 5993 BDP/FF/GB

Recruiting
  • Asthma
  • Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI
  • +2 more
  • Edegem, Antwerpen, Belgium
    SGS Belgium NV - Clinical Pharmacology Unit
Jun 1, 2023

Asthma Trial in Worldwide (Placebo, UMEC, Fluticasone Furoate)

Completed
Has Results
  • Asthma
  • Placebo
  • +3 more
  • Tempe, Arizona
  • +69 more
Oct 6, 2020